Arbutus Biopharma Corporation (FRA:I9DN)
3.394
+0.040 (1.19%)
Last updated: Jan 28, 2026, 8:02 AM CET
Arbutus Biopharma Market Cap
Arbutus Biopharma has a market cap or net worth of €668.56 million as of January 30, 2026. Its market cap has increased by 10.68% in one year.
Market Cap
668.56M
Enterprise Value
593.57M
Revenue
12.45M
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.39
Market Cap Chart
Since November 15, 2010, Arbutus Biopharma's market cap has increased from 53.50M to 668.56M, an increase of 1,149.63%. That is a compound annual growth rate of 18.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 668.56M | -15.15% |
| Dec 31, 2025 | 787.89M | 31.64% |
| Dec 31, 2024 | 598.51M | 57.80% |
| Dec 29, 2023 | 379.28M | 11.19% |
| Dec 30, 2022 | 341.13M | -26.27% |
| Dec 31, 2021 | 462.69M | 87.76% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| tonies SE | 1.14B |
| Sedlmayr Grund und Immobilien AG | 932.55M |
| Berliner Effektengesellschaft AG | 879.96M |
| Maschinenfabrik Berthold Hermle AG | 835.00M |
| Northern Data AG | 815.30M |
| Paul Hartmann AG | 763.62M |
| EUROKAI GmbH & Co. KGaA | 707.09M |
| FRoSTA Aktiengesellschaft | 658.10M |